Dealings in securities by directors, prescribed officers, and a director of a major subsidiary: Share Vesting
ADvTECH Limited
(Incorporated in the Republic of South Africa)
(Registration number 1990/001119/06)
Share code: ADH ISIN: ZAE000031035
(“ADvTECH”)
DEALINGS IN SECURITIES BY DIRECTORS, PRESCRIBED OFFICERS, AND A DIRECTOR OF A
MAJOR SUBSIDIARY: SHARE VESTING
In compliance with paragraphs 3.63 to 3.74 of the JSE Limited Listings Requirements, the following
transactions relating to directors, prescribed officer’s and a director of a major subsidiary dealings are
hereby disclosed, in terms of the provisions of the ADvTECH Management Share Incentive Scheme
(MSI), regarding performance and retention shares which have vested after 3 years.
Name of Director: RJ Douglas
Designation: Chief Executive Officer
Nature of transaction: Off-Market vesting of shares obtained in terms of
the ADvTECH Limited Management Share
Incentive Scheme (MSI).
Number of securities: 356 204
Date of Award 18 September 2019
Class of securities: Ordinary
Price of share: R17.70
Total value of transaction: R6 304 810.80
Date of transaction: 11 October 2022
Nature of interest: Direct beneficial
Name of Director: JDR Oesch
Designation: Group Commercial Director
Nature of transaction: Off-Market vesting of shares obtained in terms
of the ADvTECH Limited Management Share
Incentive Scheme (MSI).
Number of securities: 214 340
Date of Award 18 September 2019
Class of securities: Ordinary
Price of share: R17.70
Total value of transaction: R3 793 818.00
Date of transaction: 12 October 2022
Nature of interest: Direct beneficial
Name of Officer: L Wiseman
Designation: Prescribed Officer
Nature of transaction: Off-Market vesting of shares obtained in terms of
the ADvTECH Limited Management Share
Incentive Scheme (MSI).
Number of securities: 79 618
Date of Award 18 September 2019
Class of securities: Ordinary
Price of share: R17.70
Total value of transaction: R1 409 238.60
Date of transaction: 11 October 2022
Nature of interest: Direct beneficial
Name of Officer: DL Honey
Designation: Prescribed Officer
Nature of transaction: Off-Market vesting of shares obtained in terms of
the ADvTECH Limited Management Share
Incentive Scheme (MSI).
Number of securities: 217 221
Date of Award 18 September 2019
Class of securities: Ordinary
Price of share: R17.70
Total value of transaction: R3 844 811.70
Date of transaction: 11 October 2022
Nature of interest: Direct beneficial
Name of Officer: MD Aitken
Designation: Prescribed Officer
Nature of transaction: Off-Market vesting of shares obtained in terms of
the ADvTECH Limited Management Share
Incentive Scheme (MSI).
Number of securities: 183 902
Date of Award 18 September 2019
Class of securities: Ordinary
Price of share: R17.70
Total value of transaction: R3 255 065.40
Date of transaction: 11 October 2022
Nature of interest: Direct beneficial
Name of Officer: SCD Lurie
Designation: The Independent Institute of Education (Pty) Ltd
(a major subsidiary of ADvTECH)
Nature of transaction: Off-Market vesting of shares obtained in terms of
the ADvTECH Limited Management Share
Incentive Scheme (MSI).
Number of securities: 43 192
Date of Award 18 September 2019
Class of securities: Ordinary
Price of share: R17.70
Total value of transaction: R764 498.40
Date of transaction: 12 October 2022
Nature of interest: Direct beneficial
The date of vesting is 19 September 2022. In terms of paragraph 3.66 of the Listings Requirements,
the necessary clearance to deal has been obtained for all the transactions set out above.
12 October 2022
Johannesburg
Sponsor: Bridge Capital Advisors Proprietary Limited
Date: 12-10-2022 04:10:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.